Bayer Recalls Liquid Leukine For Adverse Effects
Bayer HealthCare announced Wednesday that it would withdraw the current liquid formulation of Leukine from the supply system in the United States, saying it had received an increase in reports of...To view the full article, register now.
Already a subscriber? Click here to view full article